{
  "docId": "019de518-6502-70bc-9a44-c6a9c7f323b5",
  "docSlug": "4230ce80abe7092521a593effe59cbcd",
  "documentTitle": "Oculis | Investor Presentation Deck | 48 slides",
  "authorId": "oculis",
  "authorName": "Oculis",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2024-04-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 30,
  "pageCount": 48,
  "prevPage": 29,
  "nextPage": 31,
  "slideType": "roadmap",
  "function": "plan_implementation",
  "density": "overcrowded",
  "nDataPoints": 3,
  "notes": null,
  "elementsJson": null,
  "metadataConfidence": 0.9,
  "imagePath": null,
  "slideHref": "/slides/019de518-6502-70bc-9a44-c6a9c7f323b5/30",
  "deckHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5",
  "deckJsonHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5.json",
  "deckAnchorHref": "/decks/019de518-6502-70bc-9a44-c6a9c7f323b5#slide-30",
  "components": [
    {
      "bbox": {
        "h": 0.03,
        "w": 0.109,
        "x": 0.85,
        "y": 0.04
      },
      "kind": "image",
      "text": "Oculis",
      "attrs": {},
      "subkind": "logo",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "733e52da-4344-44cc-a194-f08fa0ff7ff8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.26,
        "x": 0.547,
        "y": 0.238
      },
      "kind": "list",
      "text": "Advancing into Phase 2b for both indications",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e2661a4-f938-40aa-9d84-509f77de50c2",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.35,
        "x": 0.501,
        "y": 0.59
      },
      "kind": "list",
      "text": "Further validate CC genetic biomarker",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9e6d826e-996b-4d42-acd7-540c3f8db241",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.29,
        "x": 0.14,
        "y": 0.238
      },
      "kind": "list",
      "text": "Positive Phase 2 / PoC studies in DED and Uveitis",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab97d751-b2e5-4431-98a2-d935b7ff75c9",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.43,
        "x": 0.501,
        "y": 0.45
      },
      "kind": "list",
      "text": "Phase 2b to evaluate signs in DED (with secondary endpoint in symptoms)",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c1780c2a-1905-412d-bd47-d28ac607a52f",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.28,
        "x": 0.109,
        "y": 0.73
      },
      "kind": "list",
      "text": "Uveitis\n32 patients Phase 2 PoC\nSuccessfully completed",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "d7e1ae21-3b28-4fb9-9292-8c6a9a74b43b",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.28,
        "x": 0.109,
        "y": 0.56
      },
      "kind": "list",
      "text": "DED#2\n131 patients Phase 2 PoC\nSuccessfully completed",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "df432fe9-c399-484f-b459-a8f200f3128d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.07,
        "w": 0.28,
        "x": 0.109,
        "y": 0.39
      },
      "kind": "list",
      "text": "DED#1\n85 patients Phase 2 PoC\nSuccessfully completed",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ee0262ed-79ce-4c71-9cae-dfee03db77fe",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.45,
        "x": 0.501,
        "y": 0.76
      },
      "kind": "list",
      "text": "Phase 2b as steroid-sparing alternative for chronic and recurring Non-Infectious Anterior Uveitis",
      "attrs": {},
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "fe2f2785-1c23-46fb-a1de-c02e3bc02d91",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.016,
        "w": 0.02,
        "x": 0.936,
        "y": 0.954
      },
      "kind": "source-note",
      "text": "30",
      "attrs": {},
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b1330f3b-b5f2-46c5-a094-3939b850f987",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.02,
        "w": 0.44,
        "x": 0.026,
        "y": 0.079
      },
      "kind": "title",
      "text": "De-risked programs advancing into Phase 2b",
      "attrs": {},
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "650553fe-3ffa-427c-ba7b-e0ff297fb866",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.03,
        "w": 0.702,
        "x": 0.026,
        "y": 0.04
      },
      "kind": "title",
      "text": "OCS-02 | Positive Phase 2 Results in DED and Uveitis",
      "attrs": {},
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "556d3564-effe-4b12-8d63-d34bb8da6cb7",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Audience Definition",
      "slug": "audience-definition",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "88812804-7e27-4bca-af6a-a61da9570d8d",
      "evidence": "list/bullet: Positive Phase 2 / PoC studies in DED and Uveitis",
      "confidence": 0.7
    },
    {
      "name": "Call to action",
      "slug": "call-to-action",
      "agent": null,
      "layer": "slide",
      "matchId": "34a4c0f7-99c6-4c0f-bd03-436404026ba7",
      "evidence": "title/action-title: De-risked programs advancing into Phase 2b",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 30,
      "from": 28,
      "beatId": "a2576958-ca6f-43c8-8aa4-05628f10fd15",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Product",
      "beatSlug": "sequoia-pitch-product",
      "evidence": "The document presents OCS-02, a novel anti-TNFα eye drop",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Evidence",
      "parentBeatSlug": "evidence"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}